REPRESENTATION OF CARDIOVASCULAR DISEASE PATIENTS IN PIVOTAL CLINICAL TRIALS SUPPORTING MODERN CANCER THERAPIES

Cardiovascular disease (CVD) is common among new cancer patients. Cancer patients with concurrent CVD have poorer outcomes. Despite the high prevalence of CVD and its prognostic significance, there is limited evidence to guide CVD care and monitoring during cancer treatment. Clinical trials of new